PTC Therapeutics Completes $550 Million Convertible Notes Offering
June 22, 2026
June 22, 2026
WASHINGTON, June 22 [Category: BizLaw/Legal] -- WilmerHale, a law firm, posted the following news:
* * *
PTC Therapeutics Completes $550 Million Convertible Notes Offering
*
PTC Therapeutics, Inc. (NASDAQ: PTCT), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders, announced the pricing and closing of a $550 mi . . .
* * *
PTC Therapeutics Completes $550 Million Convertible Notes Offering
*
PTC Therapeutics, Inc. (NASDAQ: PTCT), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders, announced the pricing and closing of a $550 mi . . .